- Home
- HALO vs BXSL Comparison
HALO vs BXSL Comparison
Compare HALO & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- BXSL
- Stock Information
- Founded
- HALO 1998
- BXSL 2018
- Country
- HALO United States
- BXSL United States
- Employees
- HALO N/A
- BXSL N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- BXSL Trusts Except Educational Religious and Charitable
- Sector
- HALO Health Care
- BXSL Finance
- Exchange
- HALO Nasdaq
- BXSL Nasdaq
- Market Cap
- HALO 7.4B
- BXSL 7.5B
- IPO Year
- HALO N/A
- BXSL N/A
- Fundamental
- Price
- HALO $54.54
- BXSL $31.30
- Analyst Decision
- HALO Buy
- BXSL Buy
- Analyst Count
- HALO 9
- BXSL 6
- Target Price
- HALO $63.56
- BXSL $31.38
- AVG Volume (30 Days)
- HALO 3.3M
- BXSL 829.8K
- Earning Date
- HALO 05-06-2025
- BXSL 05-07-2025
- Dividend Yield
- HALO N/A
- BXSL 9.85%
- EPS Growth
- HALO 55.40
- BXSL N/A
- EPS
- HALO 3.76
- BXSL 3.14
- Revenue
- HALO $1,084,306,000.00
- BXSL $1,380,706,000.00
- Revenue This Year
- HALO $25.77
- BXSL $9.80
- Revenue Next Year
- HALO $18.01
- BXSL $6.52
- P/E Ratio
- HALO $14.51
- BXSL $9.96
- Revenue Growth
- HALO 25.64
- BXSL 16.76
- 52 Week Low
- HALO $42.01
- BXSL $25.89
- 52 Week High
- HALO $70.51
- BXSL $34.64
- Technical
- Relative Strength Index (RSI)
- HALO 44.48
- BXSL 57.95
- Support Level
- HALO $52.43
- BXSL $29.07
- Resistance Level
- HALO $54.26
- BXSL $32.05
- Average True Range (ATR)
- HALO 3.42
- BXSL 0.52
- MACD
- HALO -0.49
- BXSL 0.15
- Stochastic Oscillator
- HALO 30.60
- BXSL 73.21
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.